1. Home
  2. JDZG vs DVAX Comparison

JDZG vs DVAX Comparison

Compare JDZG & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JDZG

JIADE LIMITED

HOLD

Current Price

$1.22

Market Cap

5.2M

Sector

Real Estate

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$10.83

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JDZG
DVAX
Founded
2020
1996
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
1.3B
IPO Year
2024
2004

Fundamental Metrics

Financial Performance
Metric
JDZG
DVAX
Price
$1.22
$10.83
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$26.50
AVG Volume (30 Days)
13.3K
1.5M
Earning Date
04-17-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$2,567,741.00
$330,514,000.00
Revenue This Year
N/A
$24.63
Revenue Next Year
N/A
$15.85
P/E Ratio
$5.35
N/A
Revenue Growth
20.36
26.73
52 Week Low
$1.19
$9.20
52 Week High
$14.00
$14.63

Technical Indicators

Market Signals
Indicator
JDZG
DVAX
Relative Strength Index (RSI) 32.61 48.18
Support Level $1.21 $10.76
Resistance Level $1.57 $11.00
Average True Range (ATR) 0.10 0.25
MACD -0.00 -0.06
Stochastic Oscillator 2.78 20.53

Price Performance

Historical Comparison
JDZG
DVAX

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: